The role of co-occurring disruptive behavior in the clinical presentation of children and adolescents with anxiety in the context of autism spectrum disorders

Eric A. Storch, Elysse B. Arnold, Anna M. Jones, Chelsea M. Ale, Jeffrey J. Wood, Jill Ehrenreich May, Adam B. Lewin, P. Jane Mutch, Tanya K. Murphy

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

This study explored the impact of disruptive behavior disorder (DBD) comorbidity on theoretically relevant correlates among 87 children and adolescents with autism spectrum disorders (ASD) and clinically significant anxiety. Relative to youth with ASD and anxiety alone, participants with ASD, anxiety, and DBD: (a) presented with significantly more severe anxiety symptoms per clinician-, parent-, and self-report; (b) were more likely to be prescribed antipsychotic medication but were no more likely to receive additional psychosocial and educational interventions; and (c) experienced significantly greater functional impairment and family interference. These results suggest that co-occurring DBD in the context of ASD and anxiety confers greater risk for heightened symptom severity and functional impairment, and may be linked with increased prescription of antipsychotic medication.

Original languageEnglish
Pages (from-to)734-746
Number of pages13
JournalChild Psychiatry and Human Development
Volume43
Issue number5
DOIs
StatePublished - Oct 1 2012

Fingerprint

Attention Deficit and Disruptive Behavior Disorders
Anxiety
Antipsychotic Agents
Self Report
Prescriptions
Comorbidity
Autism Spectrum Disorder
Problem Behavior

Keywords

  • Anxiety
  • Asperger's Syndrome
  • Assessment
  • Autism
  • Children
  • Comorbidity
  • Oppositional defiant disorder
  • Treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

The role of co-occurring disruptive behavior in the clinical presentation of children and adolescents with anxiety in the context of autism spectrum disorders. / Storch, Eric A.; Arnold, Elysse B.; Jones, Anna M.; Ale, Chelsea M.; Wood, Jeffrey J.; Ehrenreich May, Jill; Lewin, Adam B.; Mutch, P. Jane; Murphy, Tanya K.

In: Child Psychiatry and Human Development, Vol. 43, No. 5, 01.10.2012, p. 734-746.

Research output: Contribution to journalArticle

Storch, Eric A. ; Arnold, Elysse B. ; Jones, Anna M. ; Ale, Chelsea M. ; Wood, Jeffrey J. ; Ehrenreich May, Jill ; Lewin, Adam B. ; Mutch, P. Jane ; Murphy, Tanya K. / The role of co-occurring disruptive behavior in the clinical presentation of children and adolescents with anxiety in the context of autism spectrum disorders. In: Child Psychiatry and Human Development. 2012 ; Vol. 43, No. 5. pp. 734-746.
@article{7609badca8014005b79b9222d01e4702,
title = "The role of co-occurring disruptive behavior in the clinical presentation of children and adolescents with anxiety in the context of autism spectrum disorders",
abstract = "This study explored the impact of disruptive behavior disorder (DBD) comorbidity on theoretically relevant correlates among 87 children and adolescents with autism spectrum disorders (ASD) and clinically significant anxiety. Relative to youth with ASD and anxiety alone, participants with ASD, anxiety, and DBD: (a) presented with significantly more severe anxiety symptoms per clinician-, parent-, and self-report; (b) were more likely to be prescribed antipsychotic medication but were no more likely to receive additional psychosocial and educational interventions; and (c) experienced significantly greater functional impairment and family interference. These results suggest that co-occurring DBD in the context of ASD and anxiety confers greater risk for heightened symptom severity and functional impairment, and may be linked with increased prescription of antipsychotic medication.",
keywords = "Anxiety, Asperger's Syndrome, Assessment, Autism, Children, Comorbidity, Oppositional defiant disorder, Treatment",
author = "Storch, {Eric A.} and Arnold, {Elysse B.} and Jones, {Anna M.} and Ale, {Chelsea M.} and Wood, {Jeffrey J.} and {Ehrenreich May}, Jill and Lewin, {Adam B.} and Mutch, {P. Jane} and Murphy, {Tanya K.}",
year = "2012",
month = "10",
day = "1",
doi = "10.1007/s10578-012-0294-1",
language = "English",
volume = "43",
pages = "734--746",
journal = "Child Psychiatry and Human Development",
issn = "0009-398X",
publisher = "Kluwer Academic/Human Sciences Press Inc.",
number = "5",

}

TY - JOUR

T1 - The role of co-occurring disruptive behavior in the clinical presentation of children and adolescents with anxiety in the context of autism spectrum disorders

AU - Storch, Eric A.

AU - Arnold, Elysse B.

AU - Jones, Anna M.

AU - Ale, Chelsea M.

AU - Wood, Jeffrey J.

AU - Ehrenreich May, Jill

AU - Lewin, Adam B.

AU - Mutch, P. Jane

AU - Murphy, Tanya K.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - This study explored the impact of disruptive behavior disorder (DBD) comorbidity on theoretically relevant correlates among 87 children and adolescents with autism spectrum disorders (ASD) and clinically significant anxiety. Relative to youth with ASD and anxiety alone, participants with ASD, anxiety, and DBD: (a) presented with significantly more severe anxiety symptoms per clinician-, parent-, and self-report; (b) were more likely to be prescribed antipsychotic medication but were no more likely to receive additional psychosocial and educational interventions; and (c) experienced significantly greater functional impairment and family interference. These results suggest that co-occurring DBD in the context of ASD and anxiety confers greater risk for heightened symptom severity and functional impairment, and may be linked with increased prescription of antipsychotic medication.

AB - This study explored the impact of disruptive behavior disorder (DBD) comorbidity on theoretically relevant correlates among 87 children and adolescents with autism spectrum disorders (ASD) and clinically significant anxiety. Relative to youth with ASD and anxiety alone, participants with ASD, anxiety, and DBD: (a) presented with significantly more severe anxiety symptoms per clinician-, parent-, and self-report; (b) were more likely to be prescribed antipsychotic medication but were no more likely to receive additional psychosocial and educational interventions; and (c) experienced significantly greater functional impairment and family interference. These results suggest that co-occurring DBD in the context of ASD and anxiety confers greater risk for heightened symptom severity and functional impairment, and may be linked with increased prescription of antipsychotic medication.

KW - Anxiety

KW - Asperger's Syndrome

KW - Assessment

KW - Autism

KW - Children

KW - Comorbidity

KW - Oppositional defiant disorder

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84866262870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866262870&partnerID=8YFLogxK

U2 - 10.1007/s10578-012-0294-1

DO - 10.1007/s10578-012-0294-1

M3 - Article

C2 - 22407279

AN - SCOPUS:84866262870

VL - 43

SP - 734

EP - 746

JO - Child Psychiatry and Human Development

JF - Child Psychiatry and Human Development

SN - 0009-398X

IS - 5

ER -